Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.9NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XCHNCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
XCHNCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
XCHNNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XCHNNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
XCHNUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-713.74US
XCHNUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
XCHNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCHNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCHNUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XCHNUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
XCHNYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XCHNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCHNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XCHNCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XCHNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XCHNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XCHNNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XCHNNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XCHNHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
XCHNHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
XCHNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCHNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XCHNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCHNSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JF.3NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
JF.3NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
JF.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JF.3NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
JF.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
JF.3NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
JF.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JF.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JF.3NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
JF.3NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
JF.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JF.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.11NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
EG.5.1.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.5.1.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.5.1.11NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
EG.5.1.11NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
EG.5.1.11NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
EG.5.1.11NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
EG.5.1.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.5.1.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.5.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.11NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HK.9NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used